Researchers at the University of Edinburgh have developed screening techniques that are able to identify if a patient has been exposed to a multiple organ failure initiating event, or is likely to develop multiple organ failure. More
Compositions and methods of use of A2 adenosine receptor (AR) agonists for treating conditions modulated by A2A and A2B ARs including myocardial ischemia, reperfusion injury, cystic fibrosis, erectile dysfunction, inflammation, restenosis and septic shock More